Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.
暂无分享,去创建一个
[1] F. Götz,et al. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus , 1997, Molecular microbiology.
[2] B. Berger-Bächi,et al. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus , 1997, Journal of bacteriology.
[3] R. Kennedy,et al. Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881 , 1996, Applied and environmental microbiology.
[4] O. Schneewind,et al. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. , 1995, Science.
[5] L. Heath,et al. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus , 1995, Applied and environmental microbiology.
[6] B. Berger-Bächi,et al. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus , 1993, Journal of bacteriology.
[7] A. Tomasz,et al. Abnormal Peptidoglycan Produced in a Methicillin-Resistant Strain of Staphylococcus aureus Grown in the Presence of Methicillin: Functional Role for Penicillin-Binding Protein 2A in Cell Wall Synthesis , 1993, Antimicrobial Agents and Chemotherapy.
[8] C Thornsberry,et al. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria , 1991, Journal of clinical microbiology.
[9] J. Strominger,et al. Biosynthesis of the Peptidoglycan of Bacterial Cell Walls III. THE ROLE OF SOLUBLE RIBONUCLEIC ACID AND OF LIPID INTERMEDIATES IN GLYCINE INCORPORATION IN STAPHYLOCOCCUS AUREUS , 1967 .
[10] M. Sugai,et al. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1 , 1997, Journal of bacteriology.
[11] H. Labischinski,et al. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? , 1996, Microbial drug resistance.
[12] S. Unal,et al. Cloning and characterization of femA and femB from Staphylococcus epidermidis. , 1996, Gene.
[13] F. Götz,et al. A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for Staphylococcus carnosus. , 1995, Gene.
[14] J. Strominger,et al. Biosynthesis of the peptidoglycan of bacterial cell walls. I. Utilization of uridine diphosphate acetylmuramyl pentapeptide and uridine diphosphate acetylglucosamine for peptidoglycan synthesis by particulate enzymes from Staphylococcus aureus and Micrococcus lysodeikticus. , 1966, Archives of biochemistry and biophysics.